![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1417249
°Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2030³â)Psoriatic Arthritis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 |
°Ç¼±¼º °üÀý¿° Ä¡·á µ¿Çâ ¹× Àü¸Á
¼¼°è °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 9.6%ÀÇ CAGR·Î 2030³â±îÁö ¾à 157¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í °Ç¼±¼º °üÀý¿°ÀÇ À¯º´·ü Áõ°¡, Á¦Ç° ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. °Ç¼±¼º °üÀý¿° Ä¡·á¿¡ ´ëÇÑ Áö½ÄÀÇ Áõ°¡¿Í ´õºÒ¾î °Ç¼±¼º °üÀý¿° Ä¡·á¿¡ ´ëÇÑ ½Å¾à, »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀǾàǰÀÇ °·ÂÇÑ ÆÄÀÌÇÁ¶óÀÎÀ» Á¦°øÇϱâ À§ÇØ °Ç¼±¼º °üÀý¿° Ä¡·á¿¡ ´ëÇÑ ¿¬±¸ °³¹ß Ȱµ¿ÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¼¼°è °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø ¾à±¹, ¼Ò¸Å ¾à±¹ ¹× ¿Â¶óÀÎ ¾à±¹ ½ÃÀå¿¡¼ ±âȸ°¡ ÀÖ°í À¯¸ÁÇØ º¸ÀÔ´Ï´Ù.
°Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀå¿¡ ´ëÇÑ ÀλçÀÌÆ®
LucintelÀº »ý¹°ÇÐÀû Áúȯ Á¶Àý Ç×·ù¸¶Æ¼½ºÁ¦´Â Áúº´ °ü¸®ÀÇ È¿°ú·Î ÀÎÇØ »ý¹°ÇÐÀû Ä¡·áÁ¦ÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº °Ç¼±¼º °üÀý¿° ¹ß»ý·ü°ú Á¦³×¸¯ ÀǾàǰÀÇ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q1. °Ç¼±¼º °üÀý¿° Ä¡·áÀÇ ½ÃÀå ±Ô¸ð´Â ¾î´À Á¤µµÀԴϱî?
A1. ¼¼°è °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀåÀº 2030³â±îÁö ¾à 157¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q2. °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀåÀÇ ¼ºÀå Àü¸ÁÀº ¾î´À Á¤µµÀԴϱî?
A2. ¼¼°è °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 9.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q3. °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
A3. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í °Ç¼±¼º °üÀý¿°ÀÇ À¯º´·ü Áõ°¡, °Ç¼±¼º °üÀý¿°À» Ä¡·áÇÏ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. °Ç¼±¼º °üÀý¿° Ä¡·á¿¡ ´ëÇÑ ¿¬±¸ °³¹ß ³ë·ÂÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, °Ç¼±¼º °üÀý¿° Ä¡·á¿¡ ´ëÇÑ Áö½ÄÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °Ç¼±¼º °üÀý¿°¿¡ ´ëÇÑ ½Å¾à, »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀǾàǰÀÇ °·ÂÇÑ ÆÄÀÌÇÁ¶óÀÎÀ» Á¦°øÇϱâ À§ÇÑ ¿¬±¸ °³¹ß Ȱµ¿ÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.
Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?
A4. °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø ¾à±¹, ¼Ò¸Å ¾à±¹, ¿Â¶óÀÎ ¾à±¹ ½ÃÀå¿¡¼ ±âȸ°¡ ÀÖ°í À¯¸ÁÇØ º¸ÀÔ´Ï´Ù.
Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?
A5. ÁÖ¿ä °Ç¼±¼º °üÀý¿° Ä¡·á´Â ´ÙÀ½°ú °°½À´Ï´Ù.
Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº?
A6. LucintelÀº »ý¹°ÇÐÀû Áúȯ Á¶Àý Ç×·ù¸¶Æ¼½ºÁ¦´Â Áúº´ °ü¸®ÀÇ È¿°ú·Î ÀÎÇØ »ý¹°ÇÐÀû Ä¡·áÁ¦ÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.
Q7. ½ÃÀå¿¡¼ ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº ¾îµðÀΰ¡?
A7. ¾Æ½Ã¾ÆÅÂÆò¾çÀº °Ç¼±¼º °üÀý¿° ¹ß»ý·ü°ú Á¦³×¸¯ ÀǾàǰÀÇ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q8. º¸°í¼ »ç¿ëÀÚ Á¤Àǰ¡ °¡´ÉÇմϱî?
A8. ¿¹, LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.
Psoriatic Arthritis Treatment Trends and Forecast
The future of the global psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.
A more than 150-page report is developed to help in your business decisions.
Psoriatic Arthritis Treatment by Segment
The study includes a forecast for the global psoriatic arthritis treatment by drugs class, route of administration , distribution channel, and region.
List of Psoriatic Arthritis Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psoriatic arthritis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psoriatic arthritis treatment companies profiled in this report include-
Psoriatic Arthritis Treatment Market Insights
Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.
APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.
Features of the Global Psoriatic Arthritis Treatment Market
Market Size Estimates: Psoriatic arthritis treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Psoriatic arthritis treatment market size by drugs class, route of administration , distribution channel, and region in terms of value ($B).
Regional Analysis: Psoriatic arthritis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drugs class, route of administration , distribution channel, and regions for the psoriatic arthritis treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the psoriatic arthritis treatment market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the psoriatic arthritis treatment market size?
Answer: The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030.
Q.2 What is the growth forecast for psoriatic arthritis treatment market?
Answer: The global psoriatic arthritis treatment market is expected to grow with a CAGR of 9.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the psoriatic arthritis treatment market?
Answer: The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.
Q4. What are the major segments for psoriatic arthritis treatment market?
Answer: The future of the psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.
Q5. Who are the key psoriatic arthritis treatment market companies?
Answer: Some of the key psoriatic arthritis treatment companies are as follows.
Q6. Which psoriatic arthritis treatment market segment will be the largest in future?
Answer: Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.
Q7. In psoriatic arthritis treatment market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.